-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURSymbol NRC
Symbol NRC
Währung
EUR
Börse
Börse Frankfurt Zeitzone: Europe/Berlin
Firmenname
Neuronetics, Inc
Marktkapitalisierung
377.662.976 (+- 16%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
437.325.952 oder 318.000.000
Mitarbeiter
158 (+- 23%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
122 oder 194 Mitarbeiter
EBITDA -22.780.000
PEGRatio None
Buchwert 1.449
Neuronetics Inc underperformed den DAX um -60 % vom 19.11.2018 bis 12.07.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 12,38 EUR 0,00%
Dir gefallen die Informationen zu Neuronetics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Neuronetics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Neuronetics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Neuronetics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
28 News & Informationen zur Neuronetics Inc Aktie
Neuronetics Announces Appointment of Megan Rosengarten to its Board of Directors
MALVERN, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.80% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.80%
Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 0.64% to 35,059.40 while the NASDAQ rose 0.34% to 14,731.57. The S&P also rose, gaining 0.65% to …
Mid-Day Market Update: Crude Oil Down 2%; Arcturus Therapeutics Shares Spike Higher
Midway through trading Tuesday, the Dow traded up 0.11% to 34,878.06 while the NASDAQ fell 0.37% to 14,626.97. The S&P also fell, dropping 0.01% to …
Neuronetics nears nine-month low as Q3 guidance falls short of expectations (NASDAQ:STIM)
Neuronetics (STIM) shares have lost more than a third in value to reach the lowest level since early December after the company failed to meet the analyst expectations with its Q2…
Neuronetics, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:STIM)
The following slide deck was published by Neuronetics, Inc.
Neuronetics (STIM) Reports Q2 Loss, Misses Revenue Estimates
Neuronetics (STIM) delivered earnings and revenue surprises of -20.83% and -3.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Neuronetics EPS misses by $0.05, misses on revenue (NASDAQ:STIM)
Neuronetics (STIM): Q2 GAAP EPS of -$0.29 misses by $0.05.Revenue of $14.2M (+45.8% Y/Y) misses by $0.52M.Press Release
Neuronetics To Present At The Canaccord Genuity 41st Annual Growth Conference
MALVERN, Pa., July 29, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing
Neuronetics (STIM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Neuronetics (STIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hedge Funds Have Never Been This Bullish On Neuronetics, Inc. (STIM)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided…
David J Yvars Group Buys Cowen Inc, Western Alliance Bancorp, Alphabet Inc, Sells JD.com Inc, Digital Turbine Inc, Paycom Software Inc
GuruFocus Article or News written by insider and the topic is about:
Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers
The redesigned My NeuroStar Resource Center provides user-friendly tools to help practices expand awareness of NeuroStar® Advanced Therapy for Mental…
Neuronetics to join Russell 2000 Index (NASDAQ:STIM)
Neuronetics (STIM) to be added to the Russell 2000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June…
Neuronetics Set to Join Russell 2000® Index
MALVERN, Pa., June 23, 2021 — Neuronetics, Inc. , a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life… | June 23, 2021
Neuronetics Set To Join Russell 2000® Index
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing
Neuronetics : STIM Corporate Presentation June 2021
TRANSFORMING NEUROHE ALTH
COMPANY PRESENTATION
NASDAQ: STIM
JUNE 2021
… | June 22, 2021
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors
MALVERN, Pa., April 14, 2021 — Neuronetics, Inc. , a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of… | April 14, 2021
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…
80 Biggest Movers From Yesterday
Gainers Live Ventures Incorporated (NASDAQ:LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a profit in the …
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 12) …
45 Stocks Moving in Wednesday's Pre-Market Session
Gainers Summit Midstream Partners, LP (NYSE:SMLP) shares rose 58.3% to $21.67 in pre-market trading after the company reported achievement of ke…
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Biolase (NASDAQ:BIOL) stock rose 22.11% to $1.27 during Tuesday's after-market session. At the close, Biolase's trading volume reached 14.5 …
Neuronetics (STIM) in Focus: Stock Moves 6.8% Higher
Neuronetics (STIM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Stocks That Hit 52-Week Highs On Friday
This morning 470 companies set new 52-week highs.
Facts of Interest: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a …
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 7) …
Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight
Los Angeles, USA, Jan. 05, 2021 (GLOBE NEWSWIRE) — Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight …